Edition:
India

Xenetic Biosciences Inc (XBIO.OQ)

XBIO.OQ on NASDAQ Stock Exchange Capital Market

1.87USD
23 Feb 2018
Change (% chg)

$-0.16 (-7.88%)
Prev Close
$2.03
Open
$1.99
Day's High
$1.99
Day's Low
$1.87
Volume
907
Avg. Vol
3,082
52-wk High
$5.90
52-wk Low
$1.75

Chart for

About

Xenetic Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the research and development of certain pharmaceutical products for use in humans that includes the use of the Company's platform technologies that enables the creation of drug therapies primarily for orphan indications. The... (more)
No analyst recommendations are available for .

Overall

Beta: 1.30
Market Cap(Mil.): $25.89
Shares Outstanding(Mil.): 8.72
Dividend: --
Yield (%): --

Financials

BRIEF-Xenetic Biosciences qtrly ‍loss per share $0.26​

* Xenetic Biosciences Inc- ‍current cash position is about $8.0 million, sufficient to fund operations through Q2 of 2018​‍​ Source text for Eikon: [ID: nBw9dWFZHa] Further company coverage:

15 Nov 2017

BRIEF-Xenetic Biosciences enters into sublicense agreement with subsidiary of Shire Plc

* Xenetic Biosciences enters into sublicense agreement related to its Polyxen technology with Baxalta Inc., a wholly-owned subsidiary of Shire Plc

02 Nov 2017

BRIEF-XENETIC BIOSCIENCES PROVIDES UPDATE ON ANNUAL MEETING OF STOCKHOLDERS

* XENETIC BIOSCIENCES PROVIDES UPDATE ON ANNUAL MEETING OF STOCKHOLDERS

02 Oct 2017

Competitors

Earnings vs. Estimates